Your browser doesn't support javascript.
loading
A multi-center retrospective study on the efficacy and safety of regorafenib vs. regorafenib combined with PD-1 inhibitors as a second-line therapy in patients with advanced hepatocellular carcinoma.
Yan, Tao; Huang, Chenyang; Peng, Caiyun; Duan, Xuezhang; Ji, Dong; Duan, Youjia; Zhang, Wen; Zhao, Haitao; Gao, Kun; Yang, Xiangyu; Zhang, Linzhi; Cheng, Jiamin; de Castria, Tiago Biachi; Pocha, Christine; Tsilimigras, Diamantis I; Wu, Tong; Su, Guodong; Li, Yinyin; Yu, Lingxiang; Lu, Yinying.
Afiliación
  • Yan T; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Huang C; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Peng C; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Duan X; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Ji D; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Duan Y; Department of Tumor Intervention, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Zhang W; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhao H; Department of Liver Surgery, Peking Union Medical College Hospital, Beijing, China.
  • Gao K; Department of Intervention Therapy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Yang X; Department of Intervention Therapy, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
  • Zhang L; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Cheng J; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • de Castria TB; Moffitt Cancer Center, Tampa, FL, USA.
  • Pocha C; Avera Hepatology and Transplant Institute, University of South Dakota, Sioux Falls, SD, USA.
  • Tsilimigras DI; Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, OH, USA.
  • Wu T; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Su G; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Li Y; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Yu L; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
  • Lu Y; Comprehensive HCC Center, The Fifth Medical Center of the PLA General Hospital, Beijing, China.
Ann Transl Med ; 11(2): 109, 2023 Jan 31.
Article en En | MEDLINE | ID: mdl-36819518
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: Ann Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: China